AI assistant
Cigna Group — Director's Dealing 2022
Apr 22, 2022
29918_dirs_2022-04-22_bcd5217c-bc60-495d-8820-1ed19301c2a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2022-04-20
Reporting Person: Cordani David (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-20 | Common Stock, $.01 Par Value | M | 53004.0000 | $120.8950 | Acquired | 198130.0000 | Direct |
| 2022-04-20 | Common Stock, $.01 Par Value | S | 1300.0000 | $266.3769 | Disposed | 196830.0000 | Direct |
| 2022-04-20 | Common Stock, $.01 Par Value | S | 5155.0000 | $265.3284 | Disposed | 191675.0000 | Direct |
| 2022-04-20 | Common Stock, $.01 Par Value | S | 7650.0000 | $267.8290 | Disposed | 184025.0000 | Direct |
| 2022-04-20 | Common Stock, $.01 Par Value | S | 8741.0000 | $269.2746 | Disposed | 175284.0000 | Direct |
| 2022-04-20 | Common Stock, $.01 Par Value | S | 22534.0000 | $268.4610 | Disposed | 152750.0000 | Direct |
| 2022-04-21 | Common Stock, $.01 Par Value | M | 7749.0000 | $120.8950 | Acquired | 160499.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-20 | Employee Stock Option (Right to Buy) | $120.8950 | M | 53004.0000 | Disposed | 2025-02-25 | Common Stock, $.01 Par Value (53004.0000) | Direct |
| 2022-04-21 | Employee Stock Option (Right to Buy) | $120.8950 | M | 7749.0000 | Disposed | 2025-02-25 | Common Stock, $.01 Par Value (7749.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 1677.5941 | Indirect |
| Common Stock, $.01 Par Value | 370915.0000 | Indirect |
| Common Stock, $.01 Par Value | 39795.0000 | Indirect |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2022.
F2: Represents the weighted average price of the shares sold. The prices actually received ranged from $266.00 to $266.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3: Represents the weighted average price of the shares sold. The prices actually received ranged from $265.00 to $265.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F4: Represents the weighted average price of the shares sold. The prices actually received ranged from $267.07 to $267.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F5: Represents the weighted average price of the shares sold. The prices actually received ranged from $269.00 to $269.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F6: Represents the weighted average price of the shares sold. The prices actually received ranged from $268.00 to $268.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F7: Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F8: This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.